Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer

Published:2010-12 Issue:1 Volume:298 Page:74-87
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Naderi Ali,Liu Ji

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc. Natl. Acad. Sci. USA,2001

2. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc. Natl. Acad. Sci. USA,2003

3. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis;Putti;Mod. Pathol.,2005

4. Identification of molecular apocrine breast tumours by microarray analysis;Farmer;Oncogene,2005

5. A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer;Naderi;Neoplasia,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell Effects;ACS Omega;2020-09-25

2. Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer;Scientific Reports;2019-09-16

3. Androgen receptor: A promising therapeutic target in breast cancer;Critical Reviews in Clinical Laboratory Sciences;2019-03

4. The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells;Endocrine Research;2018-03-26

5. The Role of the Androgen Receptor Signaling in Breast Malignancies;Anticancer Research;2017-12-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3